AYTU BIOPHARMA, INC Quarterly Depreciation in USD from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Aytu Biopharma, Inc quarterly/annual Depreciation history and growth rate from Q4 2010 to Q2 2024.
  • Aytu Biopharma, Inc Depreciation for the quarter ending June 30, 2024 was $100K, a 66.7% decline year-over-year.
  • Aytu Biopharma, Inc Depreciation for the twelve months ending June 30, 2024 was $900K, a 30.8% decline year-over-year.
  • Aytu Biopharma, Inc annual Depreciation for 2024 was $900K, a 30.8% decline from 2023.
  • Aytu Biopharma, Inc annual Depreciation for 2023 was $1.3M, a 18.8% decline from 2022.
  • Aytu Biopharma, Inc annual Depreciation for 2022 was $1.6M, a 167% increase from 2021.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $900K $100K -$200K -66.7% Apr 1, 2024 Jun 30, 2024 10-K 2024-09-26
Q1 2024 $1.1M $200K -$100K -33.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $1.2M $300K -$100K -25% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-14
Q3 2023 $1.3M $300K $0 0% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $1.3M $300K $0 0% Apr 1, 2023 Jun 30, 2023 10-K 2024-09-26
Q1 2023 $1.3M $300K -$200K -40% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $1.5M $400K $0 0% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-14
Q3 2022 $1.5M $300K -$100K -25% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $1.6M $300K -$149K -33.2% Apr 1, 2022 Jun 30, 2022 10-K 2023-10-12
Q1 2022 $1.75M $500K +$400K +400% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $1.35M $400K +$382K +2122% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-21
Q3 2021 $967K $400K +$367K +1112% Jul 1, 2021 Sep 30, 2021 10-Q/A 2023-02-21
Q2 2021 $600K $449K Apr 1, 2021 Jun 30, 2021 10-K 2022-09-27
Q1 2021 $100K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $18K Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-14
Q3 2020 $33K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q3 2017 $195K $80K +$61K +321% Jul 1, 2017 Sep 30, 2017 10-Q 2017-11-09
Q2 2017 $134K $62K +$48K +343% Apr 1, 2017 Jun 30, 2017 10-K 2017-08-31
Q1 2017 $86K $27K +$9K +50% Jan 1, 2017 Mar 31, 2017 10-Q 2017-05-11
Q4 2016 $77K $26K +$14K +117% Oct 1, 2016 Dec 31, 2016 10-Q 2017-02-09
Q3 2016 $63K $19K +$12K +171% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 $51K $14K Apr 1, 2016 Jun 30, 2016 10-K 2017-08-31
Q1 2016 $18K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-11
Q4 2015 $12K +$10.8K +903% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-09
Q3 2015 $7K Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-07
Q4 2014 $1.2K +$1.00 +0.08% Sep 1, 2014 Nov 30, 2014 10-Q 2015-01-12
Q4 2013 $1.2K -$91 -7.08% Sep 1, 2013 Nov 30, 2013 10-Q 2015-01-12
Q4 2012 $1.29K -$376 -22.6% Sep 1, 2012 Nov 30, 2012 10-Q 2014-01-10
Q4 2011 $1.66K +$194 +13.2% Sep 1, 2011 Nov 30, 2011 10-Q 2013-01-14
Q4 2010 $1.47K Sep 1, 2010 Nov 30, 2010 10-Q 2011-12-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.